CNXU (Conexeu Sciences) Operating Margin %: 0.00% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNXU Conexeu Sciences Inc CNXU
12 GF Score
Price $7.25
! 1 Warning Sign
View Full Analysis

What is Conexeu Sciences Operating Margin %?

Conexeu Sciences CNXU -9.91% 12 Operating Margin % is 0.00% as of Apr. 2026. GuruFocus rates CNXU with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 942 Biotechnology companies, Conexeu Sciences ranks worse than 106157.01% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Conexeu Sciences's Operating Income for the three months ended in Apr. 2026 was $-2.38 Mil. Conexeu Sciences's Revenue for the three months ended in Apr. 2026 was $0.00 Mil. Therefore, Conexeu Sciences's Operating Margin % for the quarter that ended in Apr. 2026 was 0.00%.

The historical rank and industry rank for Conexeu Sciences's Operating Margin % or its related term are showing as below:


CNXU's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.73
* Ranked among companies with meaningful Operating Margin % only.

Conexeu Sciences's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Conexeu Sciences's Operating Income for the three months ended in Apr. 2026 was $-2.38 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Apr. 2026 was $-4.10 Mil.


Conexeu Sciences  (NAS:CNXU) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Conexeu Sciences Operating Margin % Related Terms


Conexeu Sciences Operating Margin % Historical Data

* Premium members only.

The historical data trend for Conexeu Sciences's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conexeu Sciences Operating Margin % Chart

Conexeu Sciences Annual Data
Trend Oct24 Oct25
Operating Margin %
0.00 0.00

Conexeu Sciences Quarterly Data
Oct24 Jan25 Apr25 Oct25 Jan26 Apr26
Operating Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CNXU vs GALT, SRZN, RNAC: Operating Margin % Comparison

For the Biotechnology subindustry, Conexeu Sciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conexeu Sciences Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Conexeu Sciences's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Conexeu Sciences's Operating Margin % falls into.


CNXU
12GF Score
Conexeu Sciences Inc CNXU
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conexeu Sciences Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Conexeu Sciences's Operating Margin % for the fiscal year that ended in Oct. 2025 is calculated as

Operating Margin %=Operating Income (A: Oct. 2025 ) / Revenue (A: Oct. 2025 )
=-3.958 / 0
= %

Conexeu Sciences's Operating Margin % for the quarter that ended in Apr. 2026 is calculated as

Operating Margin %=Operating Income (Q: Apr. 2026 ) / Revenue (Q: Apr. 2026 )
=-2.377 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
Conexeu Sciences (CNXU) has a Operating Margin % of 0.00% as of Apr. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Conexeu Sciences and its competitors. According to the industry distribution chart, Conexeu Sciences ranks #999999 out of 942 companies in the Biotechnology industry.
Is Conexeu Sciences' Operating Margin % too high?
Conexeu Sciences' current Operating Margin % is 0.00%. Based on the distribution chart, Conexeu Sciences ranks #999999 out of 942 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Conexeu Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Conexeu Sciences' Operating Margin % compare to GALT and SRZN?
According to the Biotechnology industry distribution chart, Conexeu Sciences ranks #999999 out of 942 companies for Operating Margin %. This places Conexeu Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Conexeu Sciences and its competitors. Conexeu Sciences's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conexeu Sciences stock overvalued right now?
Conexeu Sciences (CNXU) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Conexeu Sciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Conexeu Sciences (CNXU), the current Operating Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Conexeu Sciences Business Description

Address 50 West Liberty Street, Suite 880, Reno, NV, USA, 89501
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
12GF Score

Get the complete analysis for CNXU

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.25
Price